相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Glycoxidative damage to human DNA: Neo-antigenic epitopes on DNA molecule could be a possible reason for autoimmune response in type 1 diabetes
Saheem Ahmad et al.
GLYCOBIOLOGY (2014)
Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products
Giancarlo Aldini et al.
FREE RADICAL RESEARCH (2013)
Bio-physical characterization of ribose induced glycation: A mechanistic study on DNA perturbations
Firoz Akhter et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2013)
Studies on glycation of human low density lipoprotein: A functional insight into physico-chemical analysis
Saheem Ahmad et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2013)
Oxidative Stress as an Underlying Contributor in the Development of Chronic Complications in Diabetes Mellitus
Suziy de M. Bandeira et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Genotoxic Effect of N-Hydroxy-4-Acetylaminobiphenyl on Human DNA: Implications in Bladder Cancer
Uzma Shahab et al.
PLOS ONE (2013)
Inhibitory Effect of Metformin and Pyridoxamine in the Formation of Early, Intermediate and Advanced Glycation End-Products
Saheem Ahmad et al.
PLOS ONE (2013)
Study of the urinary and faecal excretion of N ε-carboxymethyllysine in young human volunteers
Cristina Delgado-Andrade et al.
AMINO ACIDS (2012)
The in vitro inhibition effect of 2 nm gold nanoparticles on non-enzymatic glycation of human serum albumin
Champika Seneviratne et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Anti-glycation Effect of Gold Nanoparticles on Collagen
Ji-hoon Kim et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2012)
Serum Levels of Advanced Glycation End Products (AGEs) are Independent Correlates of Insulin Resistance in Nondiabetic Subjects
Nobuhiro Tahara et al.
CARDIOVASCULAR THERAPEUTICS (2012)
Chelation: A Fundamental Mechanism of Action of AGE Inhibitors, AGE Breakers, and Other Inhibitors of Diabetes Complications
Ryoji Nagai et al.
DIABETES (2012)
Glycated human DNA is a preferred antigen for anti-DNA antibodies in diabetic patients
Imran Mustafa et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2012)
Topical treatment with anti-oxidants and Au nanoparticles promote healing of diabetic wound through receptor for advance glycation end-products
Siang-An Chen et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Acquired immunogenicity of human DNA damaged by N-hydroxy-N-acetyl-4-aminobiphenyl
Uzma Shahab et al.
IUBMB LIFE (2012)
Immunological studies on glycated human IgG
Saman Ahmad et al.
LIFE SCIENCES (2012)
Hydroxyl Radical Modification of Collagen Type II Increases Its Arthritogenicity and Immunogenicity
Uzma Shahab et al.
PLOS ONE (2012)
Biomarkers in diabetes: hemoglobin A1c, vascular and tissue markers
Timothy J. Lyons et al.
TRANSLATIONAL RESEARCH (2012)
Genotoxicity and immunogenicity of DNA-advanced glycation end products formed by methylglyoxal and lysine in presence of Cu2+
Saheem Ahmad et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
The glycation of albumin: Structural and functional impacts
Philippe Rondeau et al.
BIOCHIMIE (2011)
Advanced Glycation End Products Are Direct Modulators of β-Cell Function
Melinda T. Coughlan et al.
DIABETES (2011)
AGE restriction in diabetes mellitus: a paradigm shift
Helen Vlassara et al.
NATURE REVIEWS ENDOCRINOLOGY (2011)
Potential New Therapeutic Agents for Diabetic Kidney Disease
Faruk Turgut et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
Mutagenic Potential of DNA Glycation: Miscoding by (R)- and (S)-N2-(1-Carboxyethyl)-2′-deoxyguanosine
Gerald E. Wuenschell et al.
BIOCHEMISTRY (2010)
Association of dietary AGEs with circulating AGEs, glycated LDL, IL-1α and MCP-1 levels in type 2 diabetic patients
Pei-chun Chao et al.
EUROPEAN JOURNAL OF NUTRITION (2010)
Folate-Receptor-Targeted Delivery of Doxorubicin Using Polyethylene Glycol-Functionalized Gold Nanoparticles
Bahareh Asadishad et al.
INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH (2010)
Stilbene Glucoside from Polygonum multiflorum Thunb.: A Novel Natural Inhibitor of Advanced Glycation End Product Formation by Trapping of Methylglyoxal
Lishuang Lv et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2010)
Gold nanoparticle platforms as drug and biomacromolecule delivery systems
Bradley Duncan et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Irreversibly glycated LDL induce oxidative and inflammatory state in human endothelial cells; added effect of high glucose
Laura Toma et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Inhibition of human muscle-specific enolase by methylglyoxal and irreversible formation of advanced glycation end products
Jadwiga Pietkiewicz et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2009)
Photoregulated Release of Caged Anticancer Drugs from Gold Nanoparticles
Sarit S. Agasti et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Anti-glycation activity of gold nanoparticles
Santiswarup Singha et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2009)
Multimodal drug delivery using gold nanoparticles
Chae-kyu Kim et al.
NANOSCALE (2009)
Advanced Glycation End-Product of Low Density Lipoprotein Activates the Toll-Like 4 Receptor Pathway Implications for Diabetic Atherosclerosis
Conrad P. Hodgkinson et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent
Chitta Ranjan Patra et al.
CANCER RESEARCH (2008)
Glycation as an atherogenic modification of LDL
Nahla Younis et al.
CURRENT OPINION IN LIPIDOLOGY (2008)
Glycation of paraoxonase-1 inhibits its activity and impairs the ability of high-density lipoprotein to metabolize membrane lipid hydroperoxides
M. Mastorikou et al.
DIABETIC MEDICINE (2008)
Propagation of protein glycation damage involves modification of tryptophan residues via reactive oxygen species: inhibition by pyridoxamine
Sergei V. Chetyrkin et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
Felix Kratz
JOURNAL OF CONTROLLED RELEASE (2008)
Proteomic profiling of nonenzymatically glycated proteins in human plasma and erythrocyte membranes
Qibin Zhang et al.
JOURNAL OF PROTEOME RESEARCH (2008)
The structural modification of DNA nucleosides by nonenzymatic glycation: an in vitro study based on the reactions of glyoxal and methylglyoxal with 2 '-deoxyguanosine
Yuyuan Li et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2008)
Circulating glycotoxins and dietary advanced glycation endproducts: Two links to inflammatory response, oxidative stress, and aging
Jaime Uribarri et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2007)
Gold nanoparticle-based tool to study protein conformational variants: implications in hemoglobinopathy
Jaydeep Bhattacharya et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2007)
Food-derived advanced glycation end products (AGEs): A novel therapeutic target for various disorders
Sho-ichi Yamagishi et al.
CURRENT PHARMACEUTICAL DESIGN (2007)
Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells
BD Chithrani et al.
NANO LETTERS (2006)
Colloidal gold nanoparticles: A novel nanoparticle platform for developing multifunctional tumor-targeted drug delivery vectors
Giulio F. Paciotti et al.
DRUG DEVELOPMENT RESEARCH (2006)
Well-ordered end-to-end linkage of gold nanorods
XG Hu et al.
NANOTECHNOLOGY (2005)
Nε-(carboxymethyl)lysine and 3-DG-imidazolone are major AGE structures in protein modification by 3-deoxyglucosone
T Jono et al.
JOURNAL OF BIOCHEMISTRY (2004)
'Lipoproteins, glycoxidation and diabetic angiopathy'
AJ Jenkins et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2004)
Glycation inactivation of the complement regulatory protein CD59 - A possible role in the pathogenesis of the vascular complications of human diabetes
XB Qin et al.
DIABETES (2004)
Presenting vancomycin on nanoparticles to enhance antimicrobial activities
HW Gu et al.
NANO LETTERS (2003)
Transferrin modifications and lipid peroxidation: Implications in diabetes mellitus
AV Campenhout et al.
FREE RADICAL RESEARCH (2003)
Autoimmune response to advanced glycosylation end-products of human LDL
G Virella et al.
JOURNAL OF LIPID RESEARCH (2003)
Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy
HP Hammes et al.
NATURE MEDICINE (2003)
Novel inhibitors of advanced glycation endproducts
S Rahbar et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2003)
Nε-(carboxymethyl)lysine induces γ-glutamylcysteine synthetase in RAW264.7 cells
Y Miyahara et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Biochemistry and molecular cell biology of diabetic complications
M Brownlee
NATURE (2001)
Inhibitory effect of glycation on catalytic activity of alanine aminotransferase
M Beránek et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2001)
Efficacy of benfotiamine versus thiamine on function and glycation products of peripheral nerves in diabetic rats
H Stracke et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2001)
Metabolic transit and in vivo effects of melanoidins and precursor compounds deriving from the Maillard reaction
V Faist et al.
ANNALS OF NUTRITION AND METABOLISM (2001)
In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques
Y Imanaga et al.
ATHEROSCLEROSIS (2000)
Fructose induced deactivation of antioxidant enzymes: Preventive effect of pyruvate
W Zhao et al.
FREE RADICAL RESEARCH (2000)
分享论文
